Human Activation-induced Cytidine Deaminase is Induced by IL-4 and Negatively Regulated by CD45: Implication of CD45 As a Janus Kinase Phosphatase in Antibody Diversification
Overview
Authors
Affiliations
Activation-induced cytidine deaminase (AID) plays critical roles in Ig class switch recombination and V(H) gene somatic hypermutation. We investigated the role of IL-4 in AID mRNA induction, the signaling transduction involved in IL-4-mediated AID induction, and the effect of CD45 on IL-4-dependent AID expression in human B cells. IL-4 was able to induce AID expression in human primary B cells and B cell lines, and IL-4-induced AID expression was further enhanced by CD40 signaling. IL-4-dependent AID induction was inhibited by a dominant-negative STAT6, indicating that IL-4 induced AID expression via the Janus kinase (JAK)/STAT6 signaling pathway. Moreover, triggering of CD45 with anti-CD45 Abs can inhibit IL-4-induced AID expression, and this CD45-mediated AID inhibition correlated with the ability of anti-CD45 to suppress IL-4-activated JAK1, JAK3, and STAT6 phosphorylations. Thus, in humans, IL-4 alone is sufficient to drive AID expression, and CD40 signaling is required for optimal AID production; IL-4-induced AID expression is mediated via the JAK/STAT signaling pathway, and can be negatively regulated by the JAK phosphatase activity of CD45. This study indicates that the JAK phosphatase activity of CD45 can be induced by anti-CD45 Ab treatment, and this principle may find clinical application in modulation of JAK activation in immune-mediated diseases.
Luo Y, Shreeder B, Jenkins J, Shi H, Lamichhane P, Zhou K J Immunother Cancer. 2023; 11(11).
PMID: 37918918 PMC: 10626769. DOI: 10.1136/jitc-2023-007661.
Song W, Antao O, Condiff E, Sanchez G, Chernova I, Zembrzuski K Immunity. 2022; 55(2):290-307.e5.
PMID: 35090581 PMC: 8965751. DOI: 10.1016/j.immuni.2022.01.002.
Ullah A, Mabood N, Maqbool M, Khan L, Ullah M Int J Med Sci. 2021; 18(16):3788-3793.
PMID: 34790054 PMC: 8579299. DOI: 10.7150/ijms.61779.
AID in Chronic Lymphocytic Leukemia: Induction and Action During Disease Progression.
Oppezzo P, Navarrete M, Chiorazzi N Front Oncol. 2021; 11:634383.
PMID: 34041018 PMC: 8141630. DOI: 10.3389/fonc.2021.634383.
Delgado-Benito V, Berruezo-Llacuna M, Altwasser R, Winkler W, Sundaravinayagam D, Balasubramanian S J Exp Med. 2020; 217(10).
PMID: 32609329 PMC: 7537392. DOI: 10.1084/jem.20200137.